世界のテロメラーゼ逆転写酵素市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV10516)
◆英語タイトル:Global Telomerase Reverse Transcriptase Market Insights and Forecast to 2026
◆商品コード:QYR20NV10516
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはテロメラーゼ逆転写酵素の世界市場について調査・分析した資料です。種類別(ASTVAC-1、ASTVAC-2、ETS-2300、その他)の市場規模、用途別(肺がん、卵巣がん、乳がん、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別テロメラーゼ逆転写酵素の競争状況、市場シェア
・世界のテロメラーゼ逆転写酵素市場:種類別市場規模 2015年-2020年(ASTVAC-1、ASTVAC-2、ETS-2300、その他)
・世界のテロメラーゼ逆転写酵素市場:種類別市場規模予測 2021年-2026年(ASTVAC-1、ASTVAC-2、ETS-2300、その他)
・世界のテロメラーゼ逆転写酵素市場:用途別市場規模 2015年-2020年(肺がん、卵巣がん、乳がん、その他)
・世界のテロメラーゼ逆転写酵素市場:用途別市場規模予測 2021年-2026年(肺がん、卵巣がん、乳がん、その他)
・北米のテロメラーゼ逆転写酵素市場分析:米国、カナダ
・ヨーロッパのテロメラーゼ逆転写酵素市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのテロメラーゼ逆転写酵素市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のテロメラーゼ逆転写酵素市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのテロメラーゼ逆転写酵素市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Argos Therapeutics Inc、Asterias Biotherapeutics Inc、e-Therapeutics Plc、F. Hoffmann-La Roche Ltd、Inovio Pharmaceuticals Inc、Invectys SA、Johnson & Johnson、Komipharm International Co Ltd、Mediolanum farmaceutici SpA、Telocyte LLC、TILT Biotherapeutics Ltd、Ultimovacs AS、Vaxon Biotech
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Telomerase Reverse Transcriptase Market
The global Telomerase Reverse Transcriptase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Telomerase Reverse Transcriptase Scope and Market Size
Telomerase Reverse Transcriptase market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Telomerase Reverse Transcriptase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Telomerase Reverse Transcriptase market is segmented into
ASTVAC-1
ASTVAC-2
ETS-2300
Others

Segment by Application, the Telomerase Reverse Transcriptase market is segmented into
Lung Cancer
Ovarian Cancer
Breast Cancer
Others

Regional and Country-level Analysis
The Telomerase Reverse Transcriptase market is analysed and market size information is provided by regions (countries).
The key regions covered in the Telomerase Reverse Transcriptase market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Telomerase Reverse Transcriptase Market Share Analysis
Telomerase Reverse Transcriptase market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Telomerase Reverse Transcriptase business, the date to enter into the Telomerase Reverse Transcriptase market, Telomerase Reverse Transcriptase product introduction, recent developments, etc.

The major vendors covered:
Argos Therapeutics Inc
Asterias Biotherapeutics Inc
e-Therapeutics Plc
F. Hoffmann-La Roche Ltd
Inovio Pharmaceuticals Inc
Invectys SA
Johnson & Johnson
Komipharm International Co Ltd
Mediolanum farmaceutici SpA
Telocyte LLC
TILT Biotherapeutics Ltd
Ultimovacs AS
Vaxon Biotech

【レポートの目次】

1 Study Coverage
1.1 Telomerase Reverse Transcriptase Product Introduction
1.2 Market Segments
1.3 Key Telomerase Reverse Transcriptase Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Telomerase Reverse Transcriptase Market Size Growth Rate by Type
1.4.2 ASTVAC-1
1.4.3 ASTVAC-2
1.4.4 ETS-2300
1.4.5 Others
1.5 Market by Application
1.5.1 Global Telomerase Reverse Transcriptase Market Size Growth Rate by Application
1.5.2 Lung Cancer
1.5.3 Ovarian Cancer
1.5.4 Breast Cancer
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Telomerase Reverse Transcriptase Market Size, Estimates and Forecasts
2.1.1 Global Telomerase Reverse Transcriptase Revenue 2015-2026
2.1.2 Global Telomerase Reverse Transcriptase Sales 2015-2026
2.2 Global Telomerase Reverse Transcriptase, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Telomerase Reverse Transcriptase Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Telomerase Reverse Transcriptase Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Telomerase Reverse Transcriptase Competitor Landscape by Players
3.1 Telomerase Reverse Transcriptase Sales by Manufacturers
3.1.1 Telomerase Reverse Transcriptase Sales by Manufacturers (2015-2020)
3.1.2 Telomerase Reverse Transcriptase Sales Market Share by Manufacturers (2015-2020)
3.2 Telomerase Reverse Transcriptase Revenue by Manufacturers
3.2.1 Telomerase Reverse Transcriptase Revenue by Manufacturers (2015-2020)
3.2.2 Telomerase Reverse Transcriptase Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Telomerase Reverse Transcriptase Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Telomerase Reverse Transcriptase Revenue in 2019
3.2.5 Global Telomerase Reverse Transcriptase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Telomerase Reverse Transcriptase Price by Manufacturers
3.4 Telomerase Reverse Transcriptase Manufacturing Base Distribution, Product Types
3.4.1 Telomerase Reverse Transcriptase Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Telomerase Reverse Transcriptase Product Type
3.4.3 Date of International Manufacturers Enter into Telomerase Reverse Transcriptase Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Telomerase Reverse Transcriptase Market Size by Type (2015-2020)
4.1.1 Global Telomerase Reverse Transcriptase Sales by Type (2015-2020)
4.1.2 Global Telomerase Reverse Transcriptase Revenue by Type (2015-2020)
4.1.3 Telomerase Reverse Transcriptase Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Telomerase Reverse Transcriptase Market Size Forecast by Type (2021-2026)
4.2.1 Global Telomerase Reverse Transcriptase Sales Forecast by Type (2021-2026)
4.2.2 Global Telomerase Reverse Transcriptase Revenue Forecast by Type (2021-2026)
4.2.3 Telomerase Reverse Transcriptase Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Telomerase Reverse Transcriptase Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Telomerase Reverse Transcriptase Market Size by Application (2015-2020)
5.1.1 Global Telomerase Reverse Transcriptase Sales by Application (2015-2020)
5.1.2 Global Telomerase Reverse Transcriptase Revenue by Application (2015-2020)
5.1.3 Telomerase Reverse Transcriptase Price by Application (2015-2020)
5.2 Telomerase Reverse Transcriptase Market Size Forecast by Application (2021-2026)
5.2.1 Global Telomerase Reverse Transcriptase Sales Forecast by Application (2021-2026)
5.2.2 Global Telomerase Reverse Transcriptase Revenue Forecast by Application (2021-2026)
5.2.3 Global Telomerase Reverse Transcriptase Price Forecast by Application (2021-2026)

6 North America
6.1 North America Telomerase Reverse Transcriptase by Country
6.1.1 North America Telomerase Reverse Transcriptase Sales by Country
6.1.2 North America Telomerase Reverse Transcriptase Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Telomerase Reverse Transcriptase Market Facts & Figures by Type
6.3 North America Telomerase Reverse Transcriptase Market Facts & Figures by Application

7 Europe
7.1 Europe Telomerase Reverse Transcriptase by Country
7.1.1 Europe Telomerase Reverse Transcriptase Sales by Country
7.1.2 Europe Telomerase Reverse Transcriptase Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Telomerase Reverse Transcriptase Market Facts & Figures by Type
7.3 Europe Telomerase Reverse Transcriptase Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Telomerase Reverse Transcriptase by Region
8.1.1 Asia Pacific Telomerase Reverse Transcriptase Sales by Region
8.1.2 Asia Pacific Telomerase Reverse Transcriptase Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Telomerase Reverse Transcriptase Market Facts & Figures by Type
8.3 Asia Pacific Telomerase Reverse Transcriptase Market Facts & Figures by Application

9 Latin America
9.1 Latin America Telomerase Reverse Transcriptase by Country
9.1.1 Latin America Telomerase Reverse Transcriptase Sales by Country
9.1.2 Latin America Telomerase Reverse Transcriptase Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Telomerase Reverse Transcriptase Market Facts & Figures by Type
9.3 Central & South America Telomerase Reverse Transcriptase Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Telomerase Reverse Transcriptase by Country
10.1.1 Middle East and Africa Telomerase Reverse Transcriptase Sales by Country
10.1.2 Middle East and Africa Telomerase Reverse Transcriptase Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Telomerase Reverse Transcriptase Market Facts & Figures by Type
10.3 Middle East and Africa Telomerase Reverse Transcriptase Market Facts & Figures by Application

11 Company Profiles
11.1 Argos Therapeutics Inc
11.1.1 Argos Therapeutics Inc Corporation Information
11.1.2 Argos Therapeutics Inc Description and Business Overview
11.1.3 Argos Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Argos Therapeutics Inc Telomerase Reverse Transcriptase Products Offered
11.1.5 Argos Therapeutics Inc Related Developments
11.2 Asterias Biotherapeutics Inc
11.2.1 Asterias Biotherapeutics Inc Corporation Information
11.2.2 Asterias Biotherapeutics Inc Description and Business Overview
11.2.3 Asterias Biotherapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Asterias Biotherapeutics Inc Telomerase Reverse Transcriptase Products Offered
11.2.5 Asterias Biotherapeutics Inc Related Developments
11.3 e-Therapeutics Plc
11.3.1 e-Therapeutics Plc Corporation Information
11.3.2 e-Therapeutics Plc Description and Business Overview
11.3.3 e-Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 e-Therapeutics Plc Telomerase Reverse Transcriptase Products Offered
11.3.5 e-Therapeutics Plc Related Developments
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Corporation Information
11.4.2 F. Hoffmann-La Roche Ltd Description and Business Overview
11.4.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Ltd Telomerase Reverse Transcriptase Products Offered
11.4.5 F. Hoffmann-La Roche Ltd Related Developments
11.5 Inovio Pharmaceuticals Inc
11.5.1 Inovio Pharmaceuticals Inc Corporation Information
11.5.2 Inovio Pharmaceuticals Inc Description and Business Overview
11.5.3 Inovio Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Inovio Pharmaceuticals Inc Telomerase Reverse Transcriptase Products Offered
11.5.5 Inovio Pharmaceuticals Inc Related Developments
11.6 Invectys SA
11.6.1 Invectys SA Corporation Information
11.6.2 Invectys SA Description and Business Overview
11.6.3 Invectys SA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Invectys SA Telomerase Reverse Transcriptase Products Offered
11.6.5 Invectys SA Related Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Description and Business Overview
11.7.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Johnson & Johnson Telomerase Reverse Transcriptase Products Offered
11.7.5 Johnson & Johnson Related Developments
11.8 Komipharm International Co Ltd
11.8.1 Komipharm International Co Ltd Corporation Information
11.8.2 Komipharm International Co Ltd Description and Business Overview
11.8.3 Komipharm International Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Komipharm International Co Ltd Telomerase Reverse Transcriptase Products Offered
11.8.5 Komipharm International Co Ltd Related Developments
11.9 Mediolanum farmaceutici SpA
11.9.1 Mediolanum farmaceutici SpA Corporation Information
11.9.2 Mediolanum farmaceutici SpA Description and Business Overview
11.9.3 Mediolanum farmaceutici SpA Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Mediolanum farmaceutici SpA Telomerase Reverse Transcriptase Products Offered
11.9.5 Mediolanum farmaceutici SpA Related Developments
11.10 Telocyte LLC
11.10.1 Telocyte LLC Corporation Information
11.10.2 Telocyte LLC Description and Business Overview
11.10.3 Telocyte LLC Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Telocyte LLC Telomerase Reverse Transcriptase Products Offered
11.10.5 Telocyte LLC Related Developments
11.1 Argos Therapeutics Inc
11.1.1 Argos Therapeutics Inc Corporation Information
11.1.2 Argos Therapeutics Inc Description and Business Overview
11.1.3 Argos Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Argos Therapeutics Inc Telomerase Reverse Transcriptase Products Offered
11.1.5 Argos Therapeutics Inc Related Developments
11.12 Ultimovacs AS
11.12.1 Ultimovacs AS Corporation Information
11.12.2 Ultimovacs AS Description and Business Overview
11.12.3 Ultimovacs AS Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Ultimovacs AS Products Offered
11.12.5 Ultimovacs AS Related Developments
11.13 Vaxon Biotech
11.13.1 Vaxon Biotech Corporation Information
11.13.2 Vaxon Biotech Description and Business Overview
11.13.3 Vaxon Biotech Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Vaxon Biotech Products Offered
11.13.5 Vaxon Biotech Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Telomerase Reverse Transcriptase Market Estimates and Projections by Region
12.1.1 Global Telomerase Reverse Transcriptase Sales Forecast by Regions 2021-2026
12.1.2 Global Telomerase Reverse Transcriptase Revenue Forecast by Regions 2021-2026
12.2 North America Telomerase Reverse Transcriptase Market Size Forecast (2021-2026)
12.2.1 North America: Telomerase Reverse Transcriptase Sales Forecast (2021-2026)
12.2.2 North America: Telomerase Reverse Transcriptase Revenue Forecast (2021-2026)
12.2.3 North America: Telomerase Reverse Transcriptase Market Size Forecast by Country (2021-2026)
12.3 Europe Telomerase Reverse Transcriptase Market Size Forecast (2021-2026)
12.3.1 Europe: Telomerase Reverse Transcriptase Sales Forecast (2021-2026)
12.3.2 Europe: Telomerase Reverse Transcriptase Revenue Forecast (2021-2026)
12.3.3 Europe: Telomerase Reverse Transcriptase Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Telomerase Reverse Transcriptase Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Telomerase Reverse Transcriptase Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Telomerase Reverse Transcriptase Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Telomerase Reverse Transcriptase Market Size Forecast by Region (2021-2026)
12.5 Latin America Telomerase Reverse Transcriptase Market Size Forecast (2021-2026)
12.5.1 Latin America: Telomerase Reverse Transcriptase Sales Forecast (2021-2026)
12.5.2 Latin America: Telomerase Reverse Transcriptase Revenue Forecast (2021-2026)
12.5.3 Latin America: Telomerase Reverse Transcriptase Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Telomerase Reverse Transcriptase Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Telomerase Reverse Transcriptase Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Telomerase Reverse Transcriptase Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Telomerase Reverse Transcriptase Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Telomerase Reverse Transcriptase Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Telomerase Reverse Transcriptase Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Argos Therapeutics Inc、Asterias Biotherapeutics Inc、e-Therapeutics Plc、F. Hoffmann-La Roche Ltd、Inovio Pharmaceuticals Inc、Invectys SA、Johnson & Johnson、Komipharm International Co Ltd、Mediolanum farmaceutici SpA、Telocyte LLC、TILT Biotherapeutics Ltd、Ultimovacs AS、Vaxon Biotech

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のテロメラーゼ逆転写酵素市場2026:インサイト・予測(Global Telomerase Reverse Transcriptase Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。